Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"

Active, not recruiting

• Conditions: Squamous Cell Carcinoma
• Interventions: Other: SCC metastasis

• Registration Number: NCT01976468
• Lead Sponsor: University of Zurich

Brief Summary

The investigators hypothesize that a low number of SCC in OTR will metastasize.

Detailed Description

In a large international multicenter prospective observational study a total number of 1000 OTR (organ transplant recipients) with a histologically proven cutaneous SCC (squamous cell carcinoma) will be included in 10 centers and followed during 2 years to establish the cumulative incidence of metastases in OTR with cutaneous SCC.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2013-10-29
• Study Start: 2013-11
• Study First Submitted QC: 2013-11-04
• Study First Posted: 2013-11-05
• Status Verified: 2019-07
• Last Update Submitted: 2019-07-25
• Last Update Posted: 2019-07-29
• Primary Completion: 2023-01
• Study Completion: 2025-01

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
SCC metastasis	SCC metastasis	organ transplant recipients

Primary Outcome Measures

Name	Time	Method
SCC metastasis detection	two years

Trial Locations

Locations (2)

Leiden University Medical Center; 🇳🇱 Leiden, Netherlands

University Hospital Zurich, Division of Dermatology; 🇨🇭 Zurich, ZH, Switzerland